Access to substance use disorder treatment during COVID-19: Implications from reduced local jail populations
- PMID: 33138930
- PMCID: PMC7518839
- DOI: 10.1016/j.jsat.2020.108147
Access to substance use disorder treatment during COVID-19: Implications from reduced local jail populations
Abstract
Many states have responded to the spread of COVID-19 by implementing policies which have led to a dramatic reduction in jail populations. We consider the benefits associated with providing the population of individuals who would, but for these policies, be incarcerated with substance use disorder (SUD) treatment. We discuss problems that may prevent this population from receiving SUD treatment as well as policies which may mitigate these problems.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
References
-
- American Psychiatric Association (APA) Practice guidance for COVID-19. 2020. https://bit.ly/2WkRMqO Accessed at.
-
- American Society of Addiction Medicine (ASAM) Infection control and mitigation strategies in residential treatment facilities. 2020. https://bit.ly/2WaKdT8 Accessed at.
-
- Ashwood J.S., Mehrotra A., Cowling D., Uscher-Pines L. Direct-to-consumer telehealth may increase access to care but does not decrease spending. Health Affairs. 2017;36(3):485–491. - PubMed
-
- Aslim E.G., Mungan M.C., Navarro C., Yu H. The effect of public health insurance on criminal recidivism. George Mason Law & Economics Research Paper. 2019;(19)
-
- Belenko S., Peugh J. Estimating drug treatment needs among state prison inmates. Drug and Alcohol Dependence. 2005;77(3):269–281. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical